增强型体外反搏质量控制管理与临床疗效评估中国专家共识
Expert consensus on the quality control management and clinical efficacy evaluation of enhanced external counterpulsation
中国生物医学工程学会体外反搏分会 伍贵富 1董吁钢 2张辉3
作者信息
- 1. 中山大学附属第八医院
- 2. 中山大学附属第一医院
- 3. 郑州大学第二附属医院
- 折叠
摘要
增强型体外反搏(enhanced external counterpulsation,EECP,简称"体外反搏")于20世纪80年代初成功应用于临床并相继推广到全球36个国家和地区,在慢性心脑缺血性疾病治疗和康复中发挥了重要作用,并被欧美和中国的13个临床指南和专家共识纳入推荐.由于国内外体外反搏大规模随机对照研究的数据不多,指南推荐级别还不高,随着体外反搏在心血管疾病治疗和脏器康复中的作用地位逐渐提升,开展体外反搏的机构日益增多,迫切需要对体外反搏技术的应用进行规范,并对其临床疗效作科学的评估.本专家共识基于体外反搏应用的临床需求,在体外反搏适应证选择、质量控制方法以及疗效评估手段等方面作了重点阐述,为从事体外反搏技术临床应用的医务工作者提供专业技术指导与应用规范参考.
Abstract
Since its successful application in clinical practice in the 1980s,enhanced external counterpulsation(EECP)has been gradually extended to 36 countries and regions worldwide.Today,EECP has been recommen-ded in 13 international guidelines and expert consensus documents for the treatment and rehabilitation of ischemic diseases such as coronary artery disease,angina,and stroke.With the rapid promotion and practice of cardiac re-habilitation concepts,the status of EECP in the treatment of cardiovascular diseases and organ rehabilitation are gradually rising.The present expert consensus systematically reviewed relevant literatures both domestically and internationally,and formulated corresponding recommendations including indications,quality control and manage-ment,clinical evaluations of EECP treatment,in order to promote standardized application and scientific manage-ment in the field of EECP technology to maximize the therapeutic benefits of EECP treatment.
关键词
增强型体外反搏/冠心病/专家共识/疗效评价/康复Key words
enhanced external counterpulsation/coronary artery disease/expert consensus/evaluation of clinical benefit/rehabilitation引用本文复制引用
基金项目
科技部国家重点研发计划(2020YFC2004400)
出版年
2024
NETL
NSTL
万方数据